Medicine and Dentistry
Adenocarcinoma
6%
Adjuvant Chemoradiotherapy
33%
Adjuvant Chemotherapy
7%
Adjuvant Radiotherapy
22%
Adjuvant Therapy
9%
Bile Duct Cancer
33%
Brain Metastasis
13%
Breast Cancer
81%
Breast Radiotherapy
14%
Carcinoembryonic Antigen
5%
Cervical Cancer
5%
Chemoradiotherapy
47%
Cholangiocarcinoma
8%
Conservative Treatment
5%
Disease
8%
Disease Free Survival
24%
Distant Metastasis
14%
Distant Metastasis Free Survival
16%
Extrahepatic Bile Duct
31%
Fluorouracil
7%
Gamma Urogastrone
5%
Hazard Ratio
12%
Hepatocellular Carcinoma
11%
Intensity Modulated Radiation Therapy
11%
Intraductal Carcinoma
6%
Local Recurrence Free Survival
10%
Lymph Node
22%
Lymph Node Irradiation
6%
Lymph Node Metastasis
9%
Malignant Neoplasm
10%
Mastectomy
19%
Meta-Analysis
7%
Metastatic Carcinoma
6%
Multivariate Analysis
21%
Neoadjuvant Chemotherapy
16%
Neoplasm
43%
Overall Survival
52%
Pancreas Cancer
9%
Pancreaticoduodenectomy
5%
Pelvis
8%
Phyllodes Tumor
6%
Prognostic Factor
28%
Progression Free Survival
5%
Propensity Score Matching
5%
Quadrantectomy
27%
Radiation Therapy
100%
Rectum Cancer
25%
Recurrence Free Survival
8%
Recurrent Disease
40%
Retrospective Study
24%
Squamous Cell Carcinoma
6%
Supraclavicular Lymph Node
7%
Surgery
28%
Surgical Margin
12%
Surveillance, Epidemiology, and End Results
5%
Survival Rate
23%
Systemic Therapy
7%
Univariate Analysis
6%
Volumetric Modulated Arc Therapy
7%
Whole Brain Radiotherapy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
5%
Bile Duct Cancer
18%
Brain Metastasis
6%
Breast Cancer
28%
Disease
6%
Disease Free Survival
15%
Distant Metastasis
8%
Distant Metastasis Free Survival
12%
Fluorouracil
12%
Liver Cell Carcinoma
7%
Local Recurrence Free Survival
9%
Lymph Node Metastasis
6%
Malignant Neoplasm
8%
Neoplasm
36%
Overall Survival
39%
Pancreas Cancer
11%
Phyllodes Tumor
6%
Progression Free Survival
5%
Rectum Cancer
20%
Recurrence Free Survival
8%
Recurrent Disease
27%
Retrospective Study
11%
Survival Rate
21%